Catalog
18 peptides, each with a one-line verdict and the evidence behind it. The badge shows the strongest tier any claim in the entry reaches, so an “Established” badge means at least one claim rests on an approval or a pivotal trial, not that everything does. How the tiers work.
2 of 18 peptides ·
- SemaxPreclinical
ACTH (4-10) analog
A nootropic ACTH fragment used clinically in Russia for stroke.
A short peptide derived from ACTH, studied for neuroprotection and cognition and used clinically in Russia (including in stroke). It modulates BDNF and dopamine signaling; the mechanism work is Western-indexed, but the clinical efficacy data is overwhelmingly Russian and unreplicated abroad.
No human data yet · 1 reference · Approved abroad
- SelankEmerging
Tuftsin-derived heptapeptide
A Russian anxiolytic peptide with no sedation on the label.
A synthetic analog of the immunopeptide tuftsin, developed in Russia as an anxiolytic and studied for anxiety and cognition. It is a registered prescription drug in its home market; rigorous international trial data is scarce.
No human data yet · 1 reference · Approved abroad